Neuroone Medical Technologies (NMTC) Amortization of Deferred Charges (2016 - 2024)

Neuroone Medical Technologies (NMTC) reported Amortization of Deferred Charges of $192647.0 for Q4 2024, down 63.97% sequentially from $534661.0 in Q3 2018.

Neuroone Medical Technologies (NMTC) Amortization of Deferred Charges (2016 - 2024) Analysis & Trends

Neuroone Medical Technologies has disclosed Amortization of Deferred Charges across 4 years of filings, most recently posting $192647.0 for Q4 2024.

  • Quarterly Amortization of Deferred Charges changed N/A year-over-year to $192647.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $192647.0 (changed N/A YoY) and the FY2025 annual result came in at $192647.0, up 90.12% from the prior year.
  • Amortization of Deferred Charges fell to $192647.0 in Q4 2024, from $534661.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $192647.0 in Q4 2024 and bottomed at $192647.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Neuroone Medical Technologies 26.73 Mn 23.93 Mn 990,264.00

Historic Data

Download Data
DateValue
Dec 31, 2024 192,647.00
Dec 31, 2024 192,647.00
Sep 30, 2018 534,661.00
Sep 30, 2018 534,661.00
Jun 30, 2018 141,510.00
Jun 30, 2018 141,510.00
Mar 31, 2018 70,505.00
Mar 31, 2018 70,505.00
Sep 30, 2017 284,637.00
Sep 30, 2017 284,637.00
Dec 31, 2016 4,356.00
Dec 31, 2016 4,356.00